If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Company Board Changes

16 Jul 2024 10:49

RNS Number : 6025W
Mandarin Oriental International Ltd
16 July 2024
 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

 

COMPANY BOARD CHANGES

 

 

Mandarin Oriental International Limited (the 'Company') is pleased to announce the following changes to the Board:

 

Fabrice Megarbane will join the Board of the Company as an Independent Non-Executive Director with effect from 1 August 2024.

 

John Witt, Group Managing Director of Jardine Matheson, will step down as a Director from the Company's Board and as a member of the Remuneration and Nominations Committees. Adam Keswick will step down from the Nominations Committee and Graham Baker will step down from the Remuneration Committee. Adam remains as a Director. These changes will all take effect from 22 July 2024.

 

The Company is also announcing that Sean Ward will be appointed as Company Secretary, with effect from 22 July 2024, succeeding Jonathan Lloyd.

 

Fabrice Megarbane is the Chief Global Growth Officer of L'Oréal. He was previously President and CEO of L'Oréal North Asia and CEO of L'Oréal China and serves on its global executive committee. He managed a combined revenue of more than EUR10 billion, which accounts for over 25 percent of L'Oréal's global business, and an organisation of 20,000 people. Fabrice started his marketing career at L'Oréal S.A. in 2000. He brings multi-market experience, combining emerging and developed markets, including Europe, the Middle East, Africa, Germany, China and now North Asia.

 

Commenting on these changes, Chair Ben Keswick said: "I am pleased to welcome Fabrice to our Board, which will benefit from his extensive experience at L'Oréal. He is an accomplished and passionate marketer and brand builder with a deep consumer focus and extensive experience in digital transformation.

 

We will continue to enhance the composition of our Board, bringing in relevant expertise to help our management team deliver on their strategy and build long-term shareholder value.

 

I would also like to thank John and Jonathan for their service to the Board."

 

 

Jonathan Lloyd, Jardine Matheson LimitedFor and on behalf of Mandarin Oriental International Limited

 

16th July 2024

 

www.mandarinoriental.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUBCMUPCUBQ
Date   Source Headline
5th Mar 202010:13 amRNSDirectorate Change
5th Mar 202010:03 amRNSFinal Results Mandarin Oriental International Ltd
5th Mar 202010:01 amRNSDirectorate Change
5th Mar 20209:23 amRNSMandarian Oriental International Limited
7th Feb 20207:00 amRNSNotice of 2019 Final Results
20th Jan 202010:19 amRNSDirectorate Change
20th Jan 202010:09 amRNSDirectorate Change
31st Dec 20197:03 amRNSTotal Voting Rights
13th Nov 20199:20 amRNSDirectorate Change
7th Nov 20199:45 amRNSDirectorate Change
7th Nov 20199:41 amRNSDirectorate Change
7th Nov 20199:39 amRNSDirectorate Change
7th Nov 20199:21 amRNSInterim Management Statement
2nd Oct 201910:26 amRNSDividend
25th Sep 201910:24 amRNSBlock listing Interim Review
3rd Sep 201910:23 amRNSDirector/PDMR Shareholding
2nd Aug 201911:11 amRNSDirector Declaration
1st Aug 201910:16 amRNSHalf-year Report
4th Jul 201910:23 amRNSNotice of 2019 Half-Yearly Results
8th May 20194:14 pmRNSNon-Routine Resolutions submitted via NSM
8th May 20193:58 pmRNSResult of AGM
8th May 201912:36 pmRNSInterim Management Statement
2nd May 201910:15 amRNSDividend
4th Apr 201910:20 amRNSAnnual Financial Report
29th Mar 20199:10 amRNSTotal Voting Rights
25th Mar 20199:11 amRNSBlock listing Interim Review
15th Mar 201910:46 amRNSDirector/PDMR Shareholding
13th Mar 20198:31 amRNSAdditional Listing
28th Feb 20199:06 amRNS2018 Preliminary Announcement of Results
31st Jan 20199:11 amRNSTotal Voting Rights
30th Jan 20199:09 amRNSNotice of 2018 Final Results
9th Jan 20199:14 amRNSAdditional Listing
20th Dec 201811:33 amRNSDirector Declaration
30th Nov 20189:15 amRNSTotal Voting Rights
8th Nov 20189:12 amRNSInterim Management Statement
6th Nov 20189:25 amRNSAdditional Listing
9th Oct 20187:00 amRNSREDEVELOPMENT OF THE EXCELSIOR, HONG KONG
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
26th Sep 201810:18 amRNSBlock listing Interim Review
26th Sep 201810:16 amRNSDividend
26th Jul 201810:06 amRNSHalf-year Report
23rd Jul 201810:13 amRNSDirectorate Change
28th Jun 201810:44 amRNSNotice of 2018 Half-Yearly Results
7th Jun 20187:00 amRNSMandarin Oriental International Ltd Announcement
31st May 201810:33 amRNSTotal Voting Rights
29th May 201811:01 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.